Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06500260 · ClinicalTrials.gov registry record
CNKSR2 Natural History Study
A clinical trial of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT06500260 is a study of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06500260, a study of Developmental Dysphasia and Epileptic Encephalopathy, Childhood-Onset, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective natural history study is being conducted to define the electroclinical, neurodevelopmental, and behavioral characteristics of CNKSR2 epilepsy aphasia syndrome (EAS) and intellectual disability (ID) in children aged 6 to 21 years old with CNKSR2 mutations. The data collected from this study will serve as an external control to eventual clinical trials examining precision medicine investigational therapeutics that aim to improve the seizure burden and neurodevelopmental outcomes in patients with CNKSR2 EAS/ID.
Conditions Studied
Study Locations (1)
California
- University of California, San Francisco (UCSF) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06500260
The ClinicalTrials.gov registry entry for NCT06500260 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Developmental Dysphasia appearing as the primary indexed condition, and to 0 interventions.
NCT06500260 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06500260 about?
NCT06500260 is a clinical study titled "CNKSR2 Natural History Study". This prospective natural history study is being conducted to define the electroclinical, neurodevelopmental, and behavioral characteristics of CNKSR2 epilepsy aphasia syndrome (EAS) and intellectual disability (ID) in children aged 6 to 21 years old with CNKSR2 mutations. The data collected from th...
What is the current status of trial NCT06500260?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2022-01-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06500260 study?
This clinical trial studies the following conditions: Developmental Dysphasia, Epileptic Encephalopathy, Childhood-Onset, X-Linked Intellectual Disability.
Who is sponsoring clinical trial NCT06500260?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06500260 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Developmental Dysphasia
All registered trials for this condition
Epileptic Encephalopathy, Childhood-Onset
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.